l0015na001655y
DESCRIPTION
Sample lab reportTRANSCRIPT
C000007331
SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA
CLIENT CODE :
CLIENT'S NAME AND ADDRESS :
Cert. No. M-0164
SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -
PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568
ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961
DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32
REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568
IPID: OPD-OPD FRONT OFFICE
CLINICAL INFORMATION :
Final Results Biological Reference Range UnitsTest Report Status
LIVER & KIDNEY PROFILE
ASPARTATE AMINOTRANSFERASE, SERUM
ASPARTATE AMINOTRANSFERASE (AST/SGOT) 24 15 - 37 U/LMETHOD : UV WITH P5P
ALANINE AMINOTRANSFERASE, SERUM
ALANINE AMINOTRANSFERASE (ALT/SGPT) 58 30 - 65 U/LMETHOD : UV WITH P5P
ALKALINE PHOSPHATASE, SERUM
ALKALINE PHOSPHATASE 101 50 - 136 U/LMETHOD : PNP - AMP BUFFER
* BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUMBILIRUBIN, TOTAL 0.90 0.00 - 1.00 mg/dL
METHOD : SULPH ACID DPL/CAFF-BENZ
BILIRUBIN, DIRECT 0.21 0.00 - 0.30 mg/dLMETHOD : SULPH ACID DPL/CAFF-BENZ
BILIRUBIN, INDIRECT 0.69 0.1 - 1.0 mg/dL
GAMMA GLUTAMYL TRANSFERASE, SERUM
GAMMA GLUTAMYL TRANSFERASE (GGT) 43 5 - 85 U/LMETHOD : GLUTAMYL-3-CO-4NOANILIDE
LACTATE DEHYDROGENASE, SERUM
LACTATE DEHYDROGENASE 185 85 - 227 U/LMETHOD : LACTATE -PYRUVATE UV
ALBUMIN+GLOBULIN+A/G RATIO, SERUM
ALBUMIN 4.3 3.4 - 5.0 g/dL
GLOBULIN 3.0 2.0 - 4.1 g/dL
ALBUMIN/GLOBULIN RATIO 1.4 1.0 - 2.1 RATIO
TOTAL PROTEIN, SERUM
TOTAL PROTEIN 7.3 6.4 - 8.2 g/dLMETHOD : BIURET, END POINT
BLOOD UREA NITROGEN, SERUM
BLOOD UREA NITROGEN 10 6 - 20 mg/dLMETHOD : PHOSPHOMOLYBDATE UV FORMATION
CREATININE, SERUM
CREATININE 1.1 0.9 - 1.3 mg/dLMETHOD : ALKALINE PICRATE-KINATIC
* BUN/CREAT RATIO
BUN/CREAT RATIO 9.09 5.00 - 15.00
Page 1 Of 6
C000007331
SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA
CLIENT CODE :
CLIENT'S NAME AND ADDRESS :
Cert. No. M-0164
SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -
PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568
ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961
DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32
REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568
IPID: OPD-OPD FRONT OFFICE
CLINICAL INFORMATION :
Final Results Biological Reference Range UnitsTest Report Status
ELECTROLYTES (NA/K/CL), SERUM
SODIUM 136 136 - 145 mmol/LMETHOD : INTEGRATED MULTISENSOR TECHNOLOGY
POTASSIUM 4.30 3.50 - 5.10 mmol/LMETHOD : INTEGRATED MULTISENSOR TECHNOLOGY
CHLORIDE 100 98 - 107 mmol/LMETHOD : INTEGRATED MULTISENSOR TECHNOLOGY
URIC ACID, SERUM
URIC ACID 5.4 3.5 - 7.2 mg/dLMETHOD : URICASE/CATALASE UV
URINALYSIS
COLOR PALE YELLOWMETHOD : MANUAL
APPEARANCE CLEARMETHOD : MANUAL
PH 6.0 4.7 - 7.5METHOD : REFLECTANCE SPECTROPHOTOMETRY
SPECIFIC GRAVITY 1.005 1.003 - 1.035METHOD : REFLECTANCE SPECTROPHOTOMETRY
GLUCOSE NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY
PROTEIN NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY
KETONES NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY
BLOOD NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY
BILIRUBIN NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY
UROBILINOGEN NORMAL NORMALMETHOD : REFLECTANCE SPECTROPHOTOMETRY
NITRITE NOT DETECTED NOT DETECTEDMETHOD : REFLECTANCE SPECTROPHOTOMETRY
WBC 1-2 0-5 /HPFMETHOD : MICROSCOPY
EPITHELIAL CELLS 0-1 0-5 /HPFMETHOD : MICROSCOPY
RED BLOOD CELLS NOT DETECTED NOT DETECTED /HPFMETHOD : MICROSCOPY
Page 2 Of 6
C000007331
SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA
CLIENT CODE :
CLIENT'S NAME AND ADDRESS :
Cert. No. M-0164
SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -
PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568
ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961
DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32
REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568
IPID: OPD-OPD FRONT OFFICE
CLINICAL INFORMATION :
Final Results Biological Reference RangeTest Report Status
CASTS NOT DETECTEDNOT DETECTEDMETHOD : MICROSCOPY
CRYSTALS NOT DETECTEDNOT DETECTEDMETHOD : MICROSCOPY
BACTERIA NOT DETECTED NOT DETECTEDMETHOD : MICROSCOPY
REMARKS MICROSCOPIC EXAMINATION DONE ON CENTRIFUGED URINE.METHOD : MANUAL
HAEMATOLOGY
COMPLETE BLOOD COUNT, EDTA WHOLE BLOOD/SMEARCOMPLETE BLOOD COUNT
RED BLOOD CELL COUNT 4.60 4.5 - 5.5 mil/µLMETHOD : ELECTRONIC IMPEDANCE
HEMOGLOBIN 14.1 13.0 - 17.0 g/dLMETHOD : SPECTROPHOTOMETRY
HEMATOCRIT 41.0 40 - 50 %METHOD : CALCULATED PARAMETER
MEAN CORPUSCULAR VOL 89.0 83.0 - 101.0 fLMETHOD : CALCULATED PARAMETER
MEAN CORPUSCULAR HGB. 30.7 27.0 - 32.0 pgMETHOD : CALCULATED PARAMETER
MEAN CORPUSCULAR HEMOGLOBINCONCENTRATION
34.5 31.5 - 34.5 g/dL
METHOD : CALCULATED PARAMETER
RED CELL DISTRIBUTION WIDTH 11.4 11.6 - 14.0 %Low
METHOD : CALCULATED PARAMETER
PLATELET COUNT 230 150 - 410 thou/µLMETHOD : ELECTRONIC IMPEDANCE
MEAN PLATELET VOLUME 9.8 6.8 - 10.9 fLMETHOD : CALCULATED PARAMETER
WHITE BLOOD CELL COUNT 8.4 4.0 - 10.0 thou/µLMETHOD : ELECTRONIC IMPEDANCE
WBC DIFFERENTIAL COUNT
SEGMENTED NEUTROPHILS 62 40 - 80 %METHOD : VCS TECHNOLOGY
EOSINOPHILS 02 1 - 6 %METHOD : VCS TECHNOLOGY
Page 3 Of 6
C000007331
SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA
CLIENT CODE :
CLIENT'S NAME AND ADDRESS :
Cert. No. M-0164
SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -
PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568
ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961
DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32
REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568
IPID: OPD-OPD FRONT OFFICE
CLINICAL INFORMATION :
Final Results Biological Reference RangeTest Report Status
LYMPHOCYTES 26 20 - 40 %METHOD : VCS TECHNOLOGY
MONOCYTES 10 2 - 10 %METHOD : VCS TECHNOLOGY
BASOPHILS 00 < 1 - 2 %METHOD : VCS TECHNOLOGY
COAGULATION
PROTHROMBIN TIME, PLASMA
PROTHROMBIN TIME (PT) 13.8 11.4 - 13.7 SECONDSHigh
METHOD : OPTO MECHANICAL CLOTTING TIME
INTERNATIONAL NORMALIZED RATIO (INR) 1.05 0.00 - 1.40 RATIOMETHOD : CALCULATED PARAMETER
MEAN NORMAL PT 13.2 SECONDSMETHOD : OPTO MECHANICAL CLOTTING TIME
BIO CHEMISTRY
GLUCOSE, FASTING, PLASMA / URINE
GLUCOSE, FASTING, PLASMA 99 74 - 99 mg/dLMETHOD : HEXOKINASE
GLUCOSE, POST-PRANDIAL, PLASMA/URINE
GLUCOSE, POST-PRANDIAL, PLASMA 89 74 - 140 mg/dLMETHOD : HEXOKINASE
Comments
Causes of Low Post Prandial Blood SugarThe causes of low blood sugar that occurs following a meal have been divided traditionally into(1)Alimentary(2)Functional and(3)that in diabetics and those with impaired glucose tolerance
Alimentary Hypoglycemia usually, but not necessarily , occurs in those patients who have had gastrointestinal surgery. Accelerated absorption of aglucose load leads to marked post - prandial hyperglycemia with a corresponding exaggerated insulin release thus resulting in hypoglycaemia Theensuing hypoglycemia typically occurs from one and one half to three hours after eating. This pattern of glucose intolerance and a history ofgastrointestinal surgery are suggestive of the diagnosis.
Functional Hypoglycemia is quite common in adults; it may be characterized by abnormally low plasma glucose and symptoms of light headedness,shakiness, diaphoresis, weakness, fatigue occuring with the modest withholding of food. Complaints suggestive of this syndrome commonly are seenin those who have emotional problems.
Post Prandial Hypoglycaemia in diabetics: Patients who are diabetics or who have impaired glucose tolerance also may experience reactivehypoglycemia. In these patients, hypoglycemia occurs later than in the group with the alimentary disorder, and insulin response is delayed andexaggerated.
Page 4 Of 6
C000007331
SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA
CLIENT CODE :
CLIENT'S NAME AND ADDRESS :
Cert. No. M-0164
SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -
PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568
ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961
DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32
REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568
IPID: OPD-OPD FRONT OFFICE
CLINICAL INFORMATION :
Final Results Biological Reference RangeTest Report Status
* CORONARY RISK PROFILE (LIPID PROFILE), SERUMCHOLESTEROL 103 < 200 Desirable
200 - 239 Borderline High>/= 240 High
mg/dL
METHOD : CHOLESTROL OXIDASE
TRIGLYCERIDES 110 < 150 Normal150 - 199 Borderline High200 - 499 High>/=500 Very High
mg/dL
METHOD : LIPASE / GLUCOSE DEHYDROGENASE
CHOLESTEROL HDL 33 < 40 Low>/=60 High
mg/dLLow
METHOD : PHOSPHOTUNGSTATE/MAGNESIUM
DIRECT LDL CHOLESTEROL 52 < 100 Optimal100 - 129 Near or above optimal130 - 159 Borderline High160 - 189 High>/= 190 Very High
mg/dL
METHOD : DIRECT MEASURE
CHOL/HDL RATIO 3.1 3.3 - 4.4 Low Risk4.5 - 7.0 Average Risk7.1 - 11.0 Moderate Risk> 11.0 High Risk
Low
LDL/HDL RATIO 1.6 0.5 - 3.0 Desirable/Low Risk3.1 - 6.0 Borderline/Moderate Risk>6.0 High Risk
VERY LOW DENSITY LIPOPROTEIN 22.0 </= 30.0 mg/dL
Test Method(s)GLUCOSE, FASTING, PLASMA / URINE-
ADA 2012 guidelines for adults as follows:Pre-diabetics: 100 - 125 mg/dLDiabetic: > or = 126 mg/dL
(Ref: Tietz 4th Edition & ADA 2012 Guidelines)
ENDOCRINOLOGY
THYROID PANEL II, SERUM
FREE TRIIODOTHYRONINE (FT3), SERUM
FREE TRIIODOTHYRONINE (FT3) 2.71 2.0 - 4.4 pg/mL
FREE THYROXINE (FT4), SERUM
FREE THYROXINE (FT4) 0.82 0.93 - 1.70 ng/dLLow
METHOD : ECLIA
* TSH 3RD GENERATION ULTRA( TSH3 - UL)
Page 5 Of 6
C000007331
SRL LIMITED SPLZD (OPD) - (IDA)FORTIS HOSPITAL,SECTOR - 62, NEAR HALDIRAM FACTORY,NOIDANOIDA 201301UTTAR PRADESH INDIA
CLIENT CODE :
CLIENT'S NAME AND ADDRESS :
Cert. No. M-0164
SRL LIMITED.C/O FORTIS HOSPITAL, B-22, SECTOR-62NOIDA, 201301UTTAR PRADESH, INDIATel : 0120-2403338Email : -
PATIENT NAME : AMALKUMAR ROY PATIENT ID : FHL5.118568
ACCESSION NO : 0015NA001655 AGE : 53 Years SEX : Male DATE OF BIRTH : 03/01/1961
DRAWN : 05/01/2014 09:39 RECEIVED : 05/01/2014 10:04 REPORTED : 05/01/2014 16:32
REFERRING DOCTOR : DR. Vinod Kumar Vasishtha CLIENT PATIENT ID : UHID:118568
IPID: OPD-OPD FRONT OFFICE
CLINICAL INFORMATION :
Final Results Biological Reference RangeTest Report Status
TSH 3RD GENERATION 6.920 0.27 - 4.20 µIU/mLHigh
Comments
NOTE:- S. TPC VALUES RECHECKED.
Test Method(s)FREE TRIIODOTHYRONINE (FT3), SERUM-The guidelines for age related reference ranges for FT3.---------------------------------------------------------------------------------------------------------Cord Blood 1.5 - 3.9 pg/mLChildren 2.1 - 4.4 pg/mLPregnancy 2.0 - 3.8 pg/mL---------------------------------------------------------------------------------------------------------FREE THYROXINE (FT4), SERUM-The guidlines for age related reference ranges for FT4.---------------------------------------------------------------------------------------------------------New Born (1-4 days) 2.2 - 5.3 ng/dLChildren 0.8- 2.7 ng/dL
Pregnancy1st Trimester 0.7- 2.0 ng/dL2nd & 3rd Trimester 0.5 - 1.6 ng/dL---------------------------------------------------------------------------------------------------------TSH 3RD GENERATION ULTRA( TSH3 - UL)-
**End Of Report**Please visit www.srlworld.com for related Test Information for this accession
TEST MARKED WITH '*' ARE OUTSIDE THE ACCREDITED SCOPE OF THE LABORATORY.
Dr. Neena VermaSenior Pathologist
Dr. Abhishant Pandey, MDPathologist
Dr. Sonia VijConsultant Pathologist
Dr. Noopur GuptaPathologist
Page 6 Of 6